Provided by Tiger Fintech (Singapore) Pte. Ltd.

HENLIUS

40.350
+1.4003.59%
Volume:926.69K
Turnover:36.34M
Market Cap:21.93B
PE:24.93
High:40.400
Open:38.950
Low:37.800
Close:38.950
Loading ...

Henlius 2024 Annual Results: Steady Revenue Growth With a Net Profit of RMB820.5 Million, up by 50.3% YoY

THOMSON REUTERS
·
24 Mar

Press Release: Henlius 2024 Annual Results: Steady Revenue Growth with a Net Profit of RMB820.5 million, Up by 50.3% YoY

Dow Jones
·
24 Mar

BRIEF-Shanghai Henlius Biotech Says Wenjie Zhang Re-Designated From Executive Director

Reuters
·
24 Mar

BRIEF-Shanghai Henlius Biotech Posts FY Revenue RMB 5,724.4 Million

Reuters
·
24 Mar

Shanghai Henlius Biotech FY Operating Income RMB 5,724.4 Million

THOMSON REUTERS
·
24 Mar

Shanghai Henlius Biotech Inc - Wenjie Zhang Re-Designated From an Executive Director to a Non-Executive Director

THOMSON REUTERS
·
24 Mar

Alligator Bioscience Announces FDA Orphan Drug Designation For HLX22/AC101

Reuters
·
20 Mar

Shanghai Henlius Biotech Says Orphan-Drug Designation Granted By US FDA

Reuters
·
19 Mar

Shanghai Henlius Biotech - Orphan-Drug Designation of Hlx22 (Recombinant Humanized- Anti-Her2 Monoclonal Antibody Injection) Granted by US FDA

THOMSON REUTERS
·
19 Mar

BRIEF-UBS Group's Long Position In H Shares Of Shanghai Henlius Biotech Increases To 7.55% - HKEX

Reuters
·
19 Feb

UBS Group's Long Position in H Shares of Shanghai Henlius Biotech Increases to 7.55% on Feb 13 From 5.43% - HKEX

THOMSON REUTERS
·
19 Feb

FDA Approves Shanghai Henlius Biotech's Investigational New Drug Application for Anti-Neurodegenerative Disease Drug

MT Newswires Live
·
10 Feb

Henlius Doses First Patient in Esophagus Cancer Drug Phase 2 Trial in China

MT Newswires Live
·
10 Feb

BRIEF-Shanghai Henlius Biotech's New Drug Application Of Innovative Small Molecular Hlx99 Approved By U.S. FDA

Reuters
·
10 Feb

Shanghai Henlius Biotech Inc - Co's New Drug Application of Innovative Small Molecular Hlx99 ("Hlx99") Was Approved by U.S. FDA

THOMSON REUTERS
·
10 Feb

Henlius Biotech Strikes Licensing Deal with Dr. Reddy's for Myeloma Drug

MT Newswires Live
·
07 Feb

Stock Track | HENLIUS Soars 10.81% on Deal with Dr. Reddy's Labs for Myeloma Drug

Stock Track
·
07 Feb

BUZZ-Henlius soars on deal with India's Dr. Reddy's Labs for myeloma drug

Reuters
·
07 Feb

Henlius: Co and DR. Reddy's Ink Licensing Deal for Hlx15 Expansion in Europe and U.S.

THOMSON REUTERS
·
06 Feb

BRIEF-Shanghai Henlius Biotech Says License Agreement With Dr. Reddy's For HLX15

Reuters
·
06 Feb